FibroGen (FGEN) Short Interest Ratio & Short Volume → AI Cracks Open Largest Untapped Energy Reserve on Earth (From Banyan Hill Publishing) (Ad) Free FGEN Stock Alerts $2.17 +0.08 (+3.83%) (As of 03/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability FibroGen Short Interest DataCurrent Short Volume6,520,000 sharesPrevious Short Volume7,210,000 sharesChange Vs. Previous Month-9.57%Dollar Volume Sold Short$11.15 millionShort Interest Ratio / Days to Cover2.5Last Record DateFebruary 29, 2024Outstanding Shares98,770,000 sharesFloat Size91,840,000 sharesShort Percent of Float7.10%Today's Trading Volume2,554,005 sharesAverage Trading Volume2,808,177 sharesToday's Volume Vs. Average91% Short Selling FibroGen ? Sign up to receive the latest short interest report for FibroGen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFGEN Short Interest Over TimeFGEN Days to Cover Over TimeFGEN Percentage of Float Shorted Over Time Ad Colonial MetalsCentral Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. FibroGen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20246,520,000 shares $11.15 million -9.6%7.1%2.5 $1.71 2/15/20247,210,000 shares $15.50 million -46.6%7.9%2.7 $2.15 1/31/202413,500,000 shares $25.92 million -4.9%14.7%5.1 $1.92 1/15/202414,200,000 shares $10.69 million +1.6%15.5%8.3 $0.75 12/31/202313,980,000 shares $12.39 million -3.0%15.3%7.3 $0.89 12/15/202314,410,000 shares $9.82 million -4.7%15.7%5.7 $0.68 Get the Latest News and Ratings for FGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for FibroGen and its competitors with MarketBeat's FREE daily newsletter. 11/30/202315,120,000 shares $8.35 million -1.1%16.5%4.3 $0.55 11/15/202315,290,000 shares $7.81 million +13.2%16.7%3.8 $0.51 10/31/202313,510,000 shares $7.31 million +18.0%14.9%3.3 $0.54 10/15/202311,450,000 shares $6.81 million +8.9%12.6%2.6 $0.60 9/30/202310,510,000 shares $9.07 million -3.2%11.6%2.3 $0.86 9/15/202310,860,000 shares $9.37 million +0.5%12.0%2.2 $0.86 8/31/202310,810,000 shares $10.38 million -5.7%11.9%2.7 $0.96 8/15/202311,460,000 shares $15.59 million +39.9%12.6%3.5 $1.36 7/31/20238,190,000 shares $16.87 million -2.6%9.1%2.7 $2.06 7/15/20238,410,000 shares $21.70 million +6.9%9.4%3.3 $2.58 6/30/20237,870,000 shares $21.25 million +18.9%8.8%3.6 $2.70 6/15/20236,620,000 shares $112.21 million +8.2%7.4%4.2 $16.95 5/31/20236,120,000 shares $105.57 million +7.6%6.9%6.5 $17.25 5/15/20235,690,000 shares $100.49 million +16.8%6.4%6.2 $17.66 4/30/20234,870,000 shares $83.37 million -0.2%5.7%5.4 $17.12 4/15/20234,880,000 shares $95.79 million -0.8%5.7%5.6 $19.63 3/31/20234,920,000 shares $91.81 million +1.9%5.6%5.4 $18.66 3/15/20234,830,000 shares $96.60 million +20.2%5.6%5.2 $20.00 2/28/20234,020,000 shares $89.24 million -11.3%4.6%4.4 $22.20 2/15/20234,530,000 shares $110.35 million +2.5%5.2%5.3 $24.36 1/31/20234,420,000 shares $104.31 million -24.1%5.1%5.1 $23.60 1/15/20235,820,000 shares $119.31 million -13.3%6.7%6.5 $20.50 12/30/20226,710,000 shares $107.49 million -2.2%7.7%7.6 $16.02 12/15/20226,860,000 shares $99.61 million +2.5%8.0%8.4 $14.52 11/30/20226,690,000 shares $96.14 million No Change7.8%8.5 $14.37 11/15/20226,690,000 shares $99.81 million +3.2%7.8%8.8 $14.92 10/31/20226,480,000 shares $105.49 million -4.7%7.5%8.6 $16.28 10/15/20226,800,000 shares $107.92 million +4.5%7.9%9.1 $15.87 9/30/20226,510,000 shares $84.70 million +9.8%7.6%9.8 $13.01 9/15/20225,930,000 shares $72.05 million +5.3%6.9%8.9 $12.15 8/31/20225,630,000 shares $70.04 million +10.8%6.6%7.8 $12.44 8/15/20225,080,000 shares $74.12 million +2.6%5.9%6.1 $14.59 7/31/20224,950,000 shares $62.27 million -9.2%5.8%5.1 $12.58 7/15/20225,450,000 shares $66.60 million +1.5%6.4%5.6 $12.22Did you make $29,000 two days with AI options trades? (Ad)What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy FGEN Short Interest - Frequently Asked Questions What is FibroGen's current short interest? Short interest is the volume of FibroGen shares that have been sold short but have not yet been closed out or covered. As of February 29th, traders have sold 6,520,000 shares of FGEN short. 7.10% of FibroGen's shares are currently sold short. Learn More on FibroGen's current short interest. What is a good short interest ratio for FibroGen? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FGEN shares currently have a short interest ratio of 2.0. Learn More on FibroGen's short interest ratio. Which institutional investors are shorting FibroGen? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of FibroGen: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for FibroGen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.10% of FibroGen's floating shares are currently sold short. Is FibroGen's short interest increasing or decreasing? FibroGen saw a drop in short interest in February. As of February 29th, there was short interest totaling 6,520,000 shares, a drop of 9.6% from the previous total of 7,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is FibroGen's float size? FibroGen currently has issued a total of 98,770,000 shares. Some of FibroGen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. FibroGen currently has a public float of 91,840,000 shares. How does FibroGen's short interest compare to its competitors? 7.10% of FibroGen's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to FibroGen: Theseus Pharmaceuticals, Inc. (2.63%), Kinnate Biopharma Inc. (3.56%), Seres Therapeutics, Inc. (10.66%), Inovio Pharmaceuticals, Inc. (8.09%), Mind Medicine (MindMed) Inc. (16.09%), Ocuphire Pharma, Inc. (6.81%), Avid Bioservices, Inc. (10.42%), Gracell Biotechnologies Inc. (1.64%), CorMedix Inc. (14.09%), Trevi Therapeutics, Inc. (1.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short FibroGen stock? Short selling FGEN is an investing strategy that aims to generate trading profit from FibroGen as its price is falling. FGEN shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against FibroGen? A short squeeze for FibroGen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FGEN, which in turn drives the price of the stock up even further. How often is FibroGen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FGEN, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: Theseus Pharmaceuticals Short Interest Data Kinnate Biopharma Short Interest Data Seres Therapeutics Short Interest Data Inovio Pharmaceuticals Short Interest Data Mind Medicine (MindMed) Short Interest Data Ocuphire Pharma Short Interest Data Avid Bioservices Short Interest Data Gracell Biotechnologies Short Interest Data CorMedix Short Interest Data Trevi Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FGEN) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company